Who owns Blueprint Medicines?
- Ticker: BPMC
- CUSIP Number: 09627y109
Tip: Access positions for across all investors
Analyze quarterly positions in Blueprint Medicines with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Blueprint Medicines stock
Who bought or sold Blueprint Medicines this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 26k | $2.6M | 0% | Dec 2025 |
|
| Huntington National Bank | 1.00 | $129.000000 | 0% | Dec 2025 |
|
Who sold out of Blueprint Medicines?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Van Eck Associates Corp. | Sep 2025 | 132.00 | $17k |
| Advisor Group Holdings | Sep 2025 | 23.00 | $2.9k |